[1]
I. Milošević and B. Beronja, “THE USE OF TOCILIZUMAB IN SEVERE COVID-19: A COMPREHENSIVE REVIEW : Tocilizumab and severe COVID-19”, medi, vol. 57, no. 2, May 2024, doi: 10.5937/medi57-48405.